BTig Injection contains Tigecycline | belongs to Glycylcycline antibiotic structurally related to tetracycline
Administered by IV infusion over 30 to 60 min after dilution of the reconstituted solution in 100 mL of Dextrose 5% or NaCl 0.9 %.
Reconstitution: Reconstitute the vials with 5.3 mL of NaCl 0.9% or D5W. The concentration should not exceed 1 mg/mL. The solution should be yellow to orange.
Compatibility: Dextrose 5%, NaCl 0.9%.
Stability: Reconstituted vial at room temperature for upto 6 hours with an additional 18 hours after dilution in the infusion solution or 48 hours in refrigerator.
Gl disturbances, anorexia, dizziness, phlebitis, rash, headache, abscess, infections, raised ALT, AST, BUN, amylase, prolonged APTT/PT, raised INR, pruritus, inj site reactions, impaired healing, hypoglycaemia, hypoproteinaemia, increased LFTs, hepatic failure, pseudomembranous colitis and anaphylaxis.
Adults: By IV infusion, initially 100 mg then 50 mg every 12 hr for 5-14 days. Children: Not recommended.
One of the following licensed pharmacy from the nearest location will deliver BTig Injection 50 mg 1 Vial. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts the your request based on valid prescription and availability.